These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10490146)

  • 1. DNA sequence analysis of Hb Leiden [beta6(A3) or beta7(A4) Glu-->0].
    Hoyer JD; Wick MJ; Snow K; Finkelstein W; Fairbanks VF
    Hemoglobin; 1999 Aug; 23(3):299-301. PubMed ID: 10490146
    [No Abstract]   [Full Text] [Related]  

  • 2. Double heterozygosity for Hb G-San Jose [beta7(A4)Glu-->Gly] and Hb Fukuoka [beta2(NA2)His-->Tyr] in a 2 1/2-year-old girl.
    Farah RA; Buchanan GR; Timmons CF; Phillips L; Fairbanks VF; Snow K; Hoyer JD
    Hemoglobin; 1999 Nov; 23(4):383-7. PubMed ID: 10569729
    [No Abstract]   [Full Text] [Related]  

  • 3. A new δ chain variant, Hb A2-Tunis [δ46(CD5)Gly → Glu; HBD: c.140G>A], observed in a Tunisian family in association with a compound heterozygosity for Hb C [β6(A3)Glu → Lys; HBB: c.19G>A] β(0)-thalassemia [IVS-I-1 (β143, G>A); HBB: c.92+1G>A].
    Moumni I; Zorai A; Mahjoub S; Mosbahi I; Chaouechi D; Benromdhane N; Abbes S
    Hemoglobin; 2014; 38(2):88-90. PubMed ID: 24471655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unstable hemoglobins.
    Ohba Y
    Hemoglobin; 1990; 14(4):353-88. PubMed ID: 2283293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HB Taybe: description of genetics and laboratory findings in an Israeli Arab family.
    Ben-Bassat I; Simjanovska L; Jaber L; Efremov GD
    Hemoglobin; 1998 Mar; 22(2):161-6. PubMed ID: 9576334
    [No Abstract]   [Full Text] [Related]  

  • 6. Hb Sun Prairie or alpha(2)130(H13)Ala----Pro beta 2; second observation in an Indian adult.
    Plaseska D; Gu LH; Wilson JB; Codrington JF; Huisman TH; Dash S
    Hemoglobin; 1990; 14(5):491-7. PubMed ID: 2079431
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of Hb Zürich [alpha 2 beta 2(63)(E7)His-->Arg] by DNA analysis in a Brazilian family.
    Miranda SR; Kimura EM; Saad ST; Costa FF
    Hemoglobin; 1994 Sep; 18(4-5):337-41. PubMed ID: 7852089
    [No Abstract]   [Full Text] [Related]  

  • 8. Compound heterozygosity for Hb S [β6(A3)Glu→Val] and Hb Kenya (Aγ81Leu-β86Ala) in a Ugandan woman.
    Han ZJ; Lapuz C; Rovenger JF; Dreyfus PA; Vispo BG; Ou CN; Luo HY; Chui DH; Gallivan MV
    Hemoglobin; 2012; 36(3):270-5. PubMed ID: 22384817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hb Madrid [beta115(G17)Ala-->Pro] in a Korean family with chronic hemolytic anemia.
    Kim JY; Park SS; Jung HL; Keum DH; Park H; Chang YH; Lee YJ; Cho HI
    Hemoglobin; 2000 May; 24(2):133-8. PubMed ID: 10870884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hb Castilla [beta32(B14)Leu --> Arg] caused by a de novo mutation.
    Walker L; McFarlane A; Patterson M; Eng B; Waye JS
    Hemoglobin; 2003 Nov; 27(4):253-6. PubMed ID: 14649317
    [No Abstract]   [Full Text] [Related]  

  • 11. Hb K-Ibadan [beta 46(CD5)Gly----Glu] in an Italian family.
    Castagnola M; Cassiano L; Rossetti DV; Marucci L; Ferro A; Scarano C; Monaco M; Celozzi AM
    Hemoglobin; 1990; 14(6):647-51. PubMed ID: 1983219
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of Hb Volga [beta 27(B9)Ala-->Asp] and Hb J-Wenchang-Wuming [alpha 11(A9)Lys-->Gln] in the population of the United States.
    Wang WC; Carter H; Choitz HC; Hall R; Hine TK; Jue DL; Moo-Penn WF
    Hemoglobin; 1993 Feb; 17(1):67-71. PubMed ID: 8454471
    [No Abstract]   [Full Text] [Related]  

  • 13. Hb Saint Etienne or Hb Istanbul [beta92(F8)His-->Gln] found in an Argentinean family.
    de Weinstein BI; Plaseska-Karanfilska D; Efremov GD
    Hemoglobin; 2000 May; 24(2):149-52. PubMed ID: 10870887
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical and laboratory spectrum of Hb C [β6(A3)Glu→Lys, GAG>AAG] disease.
    Cook CM; Smeltzer MP; Mortier NA; Kirk SE; Despotovic JM; Ware RE; Hankins JS
    Hemoglobin; 2013; 37(1):16-25. PubMed ID: 23297836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hb Fairfax [HBB:c.285_286insGAGCTGCACTGTGAC] in a Brazilian patient with severe hemolytic anemia-identification and functional study.
    Jorge SE; Lanaro C; Albuquerque DM; Nascimento PH; Pedroso GA; Oliveira SC; Grigoleto MRP; Santos MNN; Costa FF; Sonati MF
    Ann Hematol; 2019 Sep; 98(9):2253-2255. PubMed ID: 31253996
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemoglobin E (26 Glu-Lys) and beta-thalassemia in a Mexican family].
    Bergés-García A; del Angel-Guevara O; Ruiz-Reyes G; Dorantes-Mesa S; Ibarra B; de Ruiz NL; de Kuttel VF
    Bol Med Hosp Infant Mex; 1984 Apr; 41(4):205-10. PubMed ID: 6466420
    [No Abstract]   [Full Text] [Related]  

  • 17. Hb Tak confirmed by DNA analysis: not expressed as thalassemia in a Hb Tak/Hb E compound heterozygote.
    Hoyer JD; Wick MJ; Thibodeau SN; Viker KA; Conner R; Fairbanks VF
    Hemoglobin; 1998 Jan; 22(1):45-52. PubMed ID: 9494047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategy for identification by mass spectrometry of a new human hemoglobin variant with two mutations in Cis in the beta-globin chain: Hb S-Clichy [beta6(A3)Glu-->Val; beta8(A5)Lys-->Thr].
    Zanella-Cleon I; Préhu C; Joly P; Riou J; Becchi M; Wajcman H; Francina A
    Hemoglobin; 2009; 33(3):177-87. PubMed ID: 19657831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound heterozygosity for two alpha-globin gene defects, Hb Taybe (alpha 1; 38 or 39 minus Thr) and a poly A mutation (alpha 2; AATAAA-->AATAAG), results in a severe hemolytic anemia.
    Pobedimskaya DD; Molchanova TP; Streichman S; Huisman TH
    Am J Hematol; 1994 Nov; 47(3):198-202. PubMed ID: 7942784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous Hb Sallanches [alpha104(G11)Cys-->Tyr] in a Pakistani child with Hb H disease.
    Waye JS; Walker L; Chui DH; Lafferty J; Kirby M
    Hemoglobin; 2000 Nov; 24(4):355-7. PubMed ID: 11186268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.